Skip to search formSkip to main contentSkip to account menu

OSU 03012

Known as: 2-amino-N-(4-(5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)acetamide, AR-12 compound, OSU-03012 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Liver fibrosis may lead to portal hypertension, liver failure or hepatocellular carcinoma, and predominantly results from the… 
2013
2013
OSU-03012 is a celecoxib derivative devoid of cyclooxygenase-2 inhibitory activity. It was previously reported to inhibit the… 
2012
2012
We have further defined mechanism(s) by which the drug OSU-03012 (OSU) kills brain cancer cells. OSU toxicity was enhanced by the… 
2009
2009
1 Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada; 2 National Training Program in Allergy and Asthma… 
2008
2008
Tamoxifen is a mainstay in the treatment of estrogen receptor (ER)–positive breast cancer patients. Although the efficacy of… 
2008
2008
The manuscript by Park et al. (Mol. Pharm. (2008) mol.107.042697 / PMID: 18182481) further defines the mechanism(s) by which OSU… 
2007
2007
The epidermal growth factor receptor (EGFR) is integral to basal-like and human epidermal growth factor receptor-2 (Her-2… 
Review
2007
Review
2007
  • 2007
  • Corpus ID: 26352273
We have further defined mechanism(s) by which OSU-03012 (OSU), a derivative of the COX2 inhibitor Celecoxib but lacking COX2…